<DOC>
	<DOCNO>NCT02428010</DOCNO>
	<brief_summary>Study evaluate safety performance Twelve TMVR System</brief_summary>
	<brief_title>Twelve Transcatheter Mitral Valve Replacement ( TMVR ) Pilot Study</brief_title>
	<detailed_description>The study prospective , multi-center , non-randomized trial evaluate safety performance Twelve TMVR System high risk patient severe , symptomatic mitral regurgitation .</detailed_description>
	<mesh_term>Mitral Valve Insufficiency</mesh_term>
	<criteria>Key Severe mitral regurgitation ( MR Grade 34+ ) Symptomatic mitral regurgitation ( NYHA Class IIIV ) Transapical access deem feasible treat physician Native mitral valve geometry size compatible Twelve TMVR Key Left ventricular ejection fraction ( LVEF ) &lt; 20 Evidence intracardiac mass , thrombus , vegetation Prior valve surgery need valve surgery Prior stroke within 4 week Need coronary revascularization History , active , endocarditis Renal insufficiency ( Creatinine &gt; 2.5 mg/dL )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>